Annis Gardner Whiting Capital Advisors’s Labcorp LH Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-72	Closed	-$19.2K	–	854
2026 Q1	$19.2K	Sell	72 -6	-8%	-$1.63K	﹤0.01%	745
2025 Q4	$19.6K	Sell	78 -19	-20%	-$5.05K	﹤0.01%	660
2025 Q3	$27.8K	Buy	97 +5	+5%	+$1.34K	0.01%	560
2025 Q2	$24.2K	Buy	92 +26	+39%	+$6.33K	0.01%	534
2025 Q1	$15.4K	Hold	66	–	–	0.01%	493
2024 Q4	$15.1K	Hold	66	–	–	﹤0.01%	483
2024 Q3	$14.8K	Hold	66	–	–	﹤0.01%	504
2024 Q2	$13.4K	Sell	66 -6	-8%	-$1.22K	﹤0.01%	640
2024 Q1	$15.7K	Buy	72 +37	+106%	+$8.15K	0.01%	605
2023 Q4	$7.96K	Hold	35	–	–	﹤0.01%	498
2023 Q3	$7.04K	Buy	+35	New	+$7.38K	﹤0.01%	499

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's LH Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Labcorp (LH) in Q2 2026, closing a stake of 72 shares — an estimated $19.2K sold.

Annis Gardner Whiting Capital Advisors first reported a position in LH in Q3 2023 and held it in 11 quarters. The position peaked at $27.8K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 72 Labcorp shares in Q2 2026, an estimated $19.2K.
Annis Gardner Whiting Capital Advisors first reported a position in Labcorp in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's Labcorp position peaked at $27.8K in Q3 2025.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.